Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
15.78
+0.68 (4.50%)
At close: May 12, 2025, 4:00 PM
16.15
+0.37 (2.34%)
After-hours: May 12, 2025, 6:35 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $405.36 million as of May 12, 2025. Its market cap has increased by 2.57% in one year.
Market Cap
405.36M
Enterprise Value
156.25M
1-Year Change
2.57%
Ranking
Category
Stock Price
$15.78
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $405.36M, an increase of 82.87%. That is a compound annual growth rate of 47.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 387.90M | -25.41% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |